Koss's Cytology of the Urinary Tract with Histopathologic Correlations (eBook)

Chapter 1- IntroductionChapter 2- Indication, Collection and Laboratory Processing of Cytologic SamplesPrincipal IndicationCollection TechniquesLaboratory Processing of SamplesSuggested ReadingChapter 3- The Cellular and Acellular Components of the Urinary SedimentNormal Urothelium (Transitional Epithelium) and Its CellsOther Benign CellsNoncellular Components of the Urinary SedimentSuggested Reading Chapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection TechniqueVoided urineCytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by BrushingCytologic Makeup of Ileal Bladder UrineChapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of theLower Urinary TractInflammatory disorders Cellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferencesChapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection TechniqueVoided urineCytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by BrushingCytologic Makeup of Ileal Bladder UrineChapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of theLower Urinary TractInflammatory disorders Cellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferencesCellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferencesChapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection TechniqueVoided urineCytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by BrushingCytologic Makeup of Ileal Bladder UrineChapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of theLower Urinary TractInflammatory disorders Cellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferencesCellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferencesCellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferences